Burkehill Global Management »

Rapt Therapeutics shares owned by Burkehill Global Management

Quarter-by-quarter ownership of Rapt Therapeutics (RAPT) shares owned by Burkehill Global Management from 13F filings

Historical chart of Burkehill Global Management investment in Rapt Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapt Therapeutics held by Burkehill Global Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapt Therapeutics by Burkehill Global Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.7M 50k 33.87

More positions owned by Burkehill Global Management

Itt (ITT)
Sofi Technologies (SOFI)
Nasdaq Omx (NDAQ)
Lauder Estee Cos Cl A (EL)
Coreweave Com Cl A (CRWV)
Rollins (ROL)
Standardaero (SARO)
Medline Com Cl A (MDLN)
Realty Income (O)
Galaxy Digital Cl A (GLXY)
Figure Technology Solutio Com Cl A (FIGR)
Viking Holdings Ord Shs (VIK)
Symbotic Class A Com (SYM)
Nebius Group Shs Class A (NBIS)
Loar Holdings Com Shs (LOAR)

View all positions for Burkehill Global Management

Top funds holding Rapt Therapeutics

TCG Crossover Management
Fcpm Iii Services B.v.
OrbiMed Advisors
Rtw Investments
Foresite Capital Management VI
Siren
Vanguard Group
Frazier Life Sciences Management
Ikarian Capital
Braidwell
Soleus Capital Management
Nantahala Capital Management
Caligan Partners
State Street Corporation
Dr. Jeffrey R. Jay, M.D.

View all funds holding Rapt Therapeutics